Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nextbiomedical CoXKRX:389650 +1.82%38 OCF Yield % is 0.32 as of Aug. 27, 2026. GuruFocus rates XKRX:389650 with a GF Score™ of 38/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, Nextbiomedical Co ranks better than 79.91% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nextbiomedical Co OCF Yield % Related Terms
Nextbiomedical Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Nextbiomedical Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:389650 vs VRTX, REGN, RVMD: OCF Yield % Comparison
For the Biotechnology subindustry, Nextbiomedical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nextbiomedical Co OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nextbiomedical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Nextbiomedical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nextbiomedical Co (XKRX:389650) has a OCF Yield % of 0.32 as of Aug. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nextbiomedical Co and its competitors. According to the industry distribution chart, Nextbiomedical Co ranks #283 out of 1409 companies in the Biotechnology industry, placing it in the top 20.1%.
Is Nextbiomedical Co's OCF Yield % too high?
Nextbiomedical Co's current OCF Yield % is 0.32. Based on the distribution chart, Nextbiomedical Co ranks #283 out of 1409 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Nextbiomedical Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Nextbiomedical Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nextbiomedical Co ranks #283 out of 1409 companies for OCF Yield %. This places Nextbiomedical Co in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nextbiomedical Co and its competitors. Nextbiomedical Co's current OCF Yield % is 0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextbiomedical Co stock overvalued right now?
Nextbiomedical Co (XKRX:389650) has a current OCF Yield % of 0.32. The current OCF Yield % is 0.32. Nextbiomedical Co's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Nextbiomedical Co (XKRX:389650), the current OCF Yield % is 0.32 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.
38GF Score
Get the complete analysis for XKRX:389650
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:389650 has been successfully added to your 
